[1]邱承高,程 星,张 莹.肾衰宁胶囊联合泼尼松治疗慢性肾炎疗效及对患者肾功能和血小板的影响*[J].陕西中医,2020,(8):1088.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.019]
 QIU Chenggao,CHENG Xing,ZHANG Ying..Effect of Shenshuaining capsule combined with prednisone on chronic nephritis and its effect on renal function and platelet[J].,2020,(8):1088.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.019]
点击复制

肾衰宁胶囊联合泼尼松治疗慢性肾炎疗效及对患者肾功能和血小板的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年8期
页码:
1088
栏目:
临床研究
出版日期:
2020-08-05

文章信息/Info

Title:
Effect of Shenshuaining capsule combined with prednisone on chronic nephritis and its effect on renal function and platelet
作者:
邱承高程 星张 莹
广西壮族自治区梧州市工人医院肾内科(梧州 543001)
Author(s):
QIU ChenggaoCHENG XingZHANG Ying.
Department of Nephrology,Wuzhou Workers Hospital(Wuzhou 543001)
关键词:
肾衰宁胶囊 泼尼松 慢性肾炎 肾功能 血小板 血肌酐
Keywords:
Shenshuaining capsule Prednisone Chronic nephritis Renal function Platelet Scr
分类号:
R692.3
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.019
文献标志码:
A
摘要:
目的:探讨肾衰宁胶囊联合泼尼松治疗慢性肾炎的疗效及对肾功能和血小板的影响。方法:选择慢性肾炎患者90例。随机分为对照组与观察组,各45例,患者均采取常规对症治疗,对照组给予醋酸泼尼松片治疗,观察组在对照组用药基础上给予肾衰宁胶囊治疗,比较两组治疗前后中医证候积分、血肌酐(Scr)、尿素氮(BUN)、 24 h尿蛋白定量(24 h Upro)、血小板计数(PLT)变化及临床疗效。观察治疗3个月后,两组生活质量情况。结果: 治疗后,两组中医证候积分明显下降(P<0.05)。治疗后,两组Scr、BUN、24 h Upro水平均降低,PLT水平均升高(P<0.05); 观察组治疗后Scr、BUN、24 h Upro水平均低于对照组,PLT水平高于对照组(P<0.05); 观察组总有效率88.89%高于对照组71.11%(P<0.05); 两组临床不良反应发生率比较,差异无统计学意义(P>0.05)。两组治疗后生活质量评分升高,观察组与对照组比较,差异具有统计学意义(P<0.05)。结论:肾衰宁胶囊联合泼尼松可显著改善慢性肾炎患者肾功能,提高血小板水平。
Abstract:
Objective:To investigate the effect of Shenshuaining capsule combined with prednisone on chronic nephritis and its effect on renal function and platelet.Methods:90 patients with chronic nephritis were selected.Randomly divided into control group and observation group,45 cases in each group.The patients were treated with routine symptomatic treatment.The control group was treated with prednisone acetate tablet.The observation group was treated with Shenshuaining capsule on the basis of the control group.Results:After 1,2 and 3 months of treatment,the TCM syndrome scores of the two groups were significantly reduced,and the observation group was more obvious(P<0.05).After the treatment,the levels of Scr,BUN and 24 h Upro decreased and PLT increased in the two groups(P<0.05).after the treatment,the levels of Scr,BUN and 24 h in the observation group increased(P<0.05).Upro level was lower than that of the control group,PLT level was higher than that of the control group(P<0.05).The total effective rate of the observation group was higher than that of the control group(P<0.05).There was no significant difference in the incidence of clinical adverse reactions between the two groups(P>0.05).After treatment,the quality of life scores of the two groups were significantly higher than that of the control group(P<0.05).Conclusion:Shenshuaining capsule combined with prednisone can significantly improve the renal function of patients with chronic nephritis,improve the level of platelet.

参考文献/References:

[1] 张 微,熊 军,王景平,等.缬沙坦联合前列地尔对慢性肾小球肾炎患者肾功能、免疫指标及其细胞因子的影响[J].疑难病杂志,2017,16(12):1236-1239.
[2] 何明清,张跃强,胡彦辉,等.益肾化瘀汤联合中药免疫抑制剂治疗慢性肾炎患者及对尿蛋白、肾纤维化的影响[J].世界中医药,2019,14(6):1507-1510.
[3] 党同光,满中萍,景舒梦.阿托伐他汀联合缬沙坦治疗慢性肾炎患者的临床有效率分析[J].国际医药卫生导报,2019,25(9):1454-1456.
[4] 曹 飞.阿托伐他汀与依那普利分别联合缬沙坦治疗慢性肾炎的临床对比[J].国际医药卫生导报,2019,25(22):3766-3768.
[5] 周 婷,孟令栋,蒋红心,等.补脾益肾清利法联合雷公藤多苷片治疗慢性肾小球肾炎临床研究[J].陕西中医,2018,39(7):906-909.
[6] 尹 洁.小柴胡汤改善慢性肾小球肾炎患者炎症及减轻蛋白尿的作用探讨[J].中国医药指南,2018,16(13):237-238.
[7] 孙建明,郑媛媛,江珍珍.彩色多普勒频谱和超声造影定量分析在慢性肾炎治疗前后肾脏微循环评估中的价值[J].中华全科医学,2017,15(1):125-127.
[8] 赵庆瑞.针对性治疗原发性肾病综合征并发急性肾功能衰竭的疗效及对患者生活质量的影响[J].临床合理用药杂志,2016,9(7):124-125.
[9] 李旭东.慢性肾炎运用肾炎康复片联合氯沙坦钾治疗的疗效观察[J].心血管病防治知识:学术版,2017,28(7):856-858.
[10] 崔红权.血清视黄醇结合蛋白与胱抑素C联合检测在肾脏疾病临床诊断中的价值分析[J].中国卫生检验杂志,2017,27(23):3425-3427.
[11] 张科伟,郭 静.中西医结合治疗慢性肾炎脾肾气虚证43例临床观察[J].湖南中医杂志,2018,35(7):11-12.
[12] 齐梦海.泼尼松治疗原发性肾病综合征50例疗效对比分析[J].陕西医学杂志,2014,43(5):609-610.
[13] 胡 泳,方立明,韦 玲.肾衰宁联合α-酮酸对慢性肾功能不全患者营养状况、超敏C反应蛋白及肾功能的影响[J].中医学报,2017,23(12):2497-2500.
[14] 何香芝,宋晓丽,王红翠.丹参川芎嗪注射液联合骨化三醇对慢性肾衰竭患者的治疗效果[J].中国临床实用医学,2018,9(2):35-37.
[15] 陈志红,卢春键,袁常健,等.基于数据挖掘分析易无庸教授治疗慢性肾衰随诊6年中药处方[J].世界中医药,2019,14(6):1598-1601.

备注/Memo

备注/Memo:
*广西壮族自治区卫生健康委员会自筹经费科研项目(Z20191053)
更新日期/Last Update: 2020-08-10